Provention bio announces the grant of inducement awards

Red bank, n.j. , january 6, 2023 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options to 58 non-executive employees to purchase an aggregate of 763,000 shares of common stock.
PRVB Ratings Summary
PRVB Quant Ranking